The DOI matches its Crossref record; 314 of the 314 references it cites were found in a registry or an index.
Controlling timing and location in vaccines
Open accessAbstract
Vaccines are one of the most powerful technologies supporting public health. The adaptive immune response induced by immunization arises following appropriate activation and differentiation of T and B cells in lymph nodes. Among many parameters impacting the resulting immune response, the presence of antigen and inflammatory cues for an appropriate temporal duration within the lymph nodes, and further within appropriate subcompartments of the lymph nodes- the right timing and location- play a critical role in shaping cellular and humoral immunity. Here we review recent advances in our understanding of how vaccine kinetics and biodistribution impact adaptive immunity, and the underlying immunological mechanisms that govern these responses. We discuss emerging approaches to engineer these properties for future vaccines, with a focus on subunit vaccines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
Kantoff, P. W., Higano, C. S., Shore, N. D., Berger, E. R., Small, E. J., Penson, D. F., Redfern, C. H., Ferrari, A. C., Dreicer, R., Sims, R. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001294 · Cited by 5,572
Designing hydrogels for controlled drug delivery
Li, J., & Mooney, D. J. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.71 · Cited by 4,832
mRNA vaccines — a new era in vaccinology
Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.243 · Cited by 4,667
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Control of adaptive immunity by the innate immune system
Iwasaki, A., & Medzhitov, R. (2015) · Nature Immunology · doi:10.1038/ni.3123 · Cited by 2,160 · cited 2×
“These antigen recognition eventsmust occur in the context inflammatory cues that direct the type of immune response the immune system should mount to the antigen [27]- such inflammatory cues come in the formofmolecules that activate innate immune system pattern recognition receptors (e.”
Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Kranz, L. M., Diken, M., Haas, H., Kreiter, S., Loquai, C., Reuter, K. C., Meng, M., Fritz, D., Vascotto, F., Hefesha, H., et al. (2016) · Nature · doi:10.1038/nature18300 · Cited by 1,819
Correlates of protection induced by vaccination
Plotkin, S. A. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00131-10 · Cited by 1,745
Developing Covid-19 Vaccines at Pandemic Speed
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557
Crucial role for the Nalp3 inflammasome in the immunostimulatory properties of aluminium adjuvants
Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S., & Flavell, R. A. (2008) · Nature · doi:10.1038/nature06939 · Cited by 1,542
The generation of antibody-secreting plasma cells
Nutt, S. L., Hodgkin, P. D., Tarlinton, D. M., & Corcoran, L. M. (2015) · Nature Reviews Immunology · doi:10.1038/nri3795 · Cited by 1,454
Key roles of adjuvants in modern vaccines
Reed, S. G., Orr, M. T., & Fox, C. B. (2013) · Nature Medicine · doi:10.1038/nm.3409 · Cited by 1,419
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Reddy, S. T., van der Vlies, A. J., Simeoni, E., Angeli, V., Randolph, G. J., O'Neil, C. P., Lee, L. K., Swartz, M. A., & Hubbell, J. A. (2007) · Nature Biotechnology · doi:10.1038/nbt1332 · Cited by 1,350
Nanoparticles target distinct dendritic cell populations according to their size
Manolova, V., Flace, A., Bauer, M., Schwarz, K., Saudan, P., & Bachmann, M. F. (2008) · European Journal of Immunology · doi:10.1002/eji.200737984 · Cited by 1,289
Mucosal vaccines: the promise and the challenge
Neutra, M. R., & Kozlowski, P. A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1777 · Cited by 1,223
C3d of complement as a molecular adjuvant: Bridging innate and acquired immunity
Dempsey, P. W., Allison, M. E. D., Akkaraju, S., Goodnow, C. C., & Fearon, D. T. (1996) · Science · doi:10.1126/science.271.5247.348 · Cited by 1,197
Delivering the Messenger: Advances in Technologies for Therapeutic mRNA Delivery
Kowalski, P. S., Rudra, A., Miao, L., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.02.012 · Cited by 1,127
SARS-CoV-2 Vaccines: Status Report
Amanat, F., & Krammer, F. (2020) · Immunity · doi:10.1016/j.immuni.2020.03.007 · Cited by 1,120
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
Cunningham, A. L., Lal, H., Kovac, M., Chlibek, R., Hwang, S.-J., Díez-Domingo, J., Godeaux, O., Levin, M. J., McElhaney, J. E., Puig-Barberà, J., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603800 · Cited by 1,070
Tissue-Resident Memory T Cells
Schenkel, J. M., & Masopust, D. (2014) · Immunity · doi:10.1016/j.immuni.2014.12.007 · Cited by 1,059 · cited 1×
“T cells provide a rapid response to subsequent encounter with a pathogen, and can further localize in peripheral tissues to provide a nearimmediate antigen-specific first line of defense, bolstering the protection provided by innate immunity [25].”
Designer vaccine nanodiscs for personalized cancer immunotherapy
Kuai, R., Ochyl, L. J., Bahjat, K. S., Schwendeman, A., & Moon, J. J. (2017) · Nature Materials · doi:10.1038/nmat4822 · Cited by 1,056
Pardi, N., Tuyishime, S., Muramatsu, H., Kariko, K., Mui, B. L., Tam, Y. K., Madden, T. D., Hope, M. J., & Weissman, D. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.007 · Cited by 1,014
Germinal Center B Cell Dynamics
Mesin, L., Ersching, J., & Victora, G. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.001 · Cited by 994
Programming the magnitude and persistence of antibody responses with innate immunity
Kasturi, S. P., Skountzou, I., Albrecht, R. A., Koutsonanos, D., Hua, T., Nakaya, H. I., Ravindran, R., Stewart, S., Alam, M., Kwissa, M., et al. (2011) · Nature · doi:10.1038/nature09737 · Cited by 975
Structure-based programming of lymph-node targeting in molecular vaccines
Liu, H., Moynihan, K. D., Zheng, Y., Szeto, G. L., Li, A. V., Huang, B., Van Egeren, D. S., Park, C., & Irvine, D. J. (2014) · Nature · doi:10.1038/nature12978 · Cited by 943
Self-citationBonifaz, L. C., Bonnyay, D. P., Charalambous, A., Darguste, D. I., Fujii, S.-I., Soares, H., Brimnes, M. K., Moltedo, B., Moran, T. M., & Steinman, R. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20032220 · Cited by 921
Differentiation of Phagocytic Monocytes into Lymph Node Dendritic Cells In Vivo
Randolph, G. J., Inaba, K., Robbiani, D. F., Steinman, R. M., & Muller, W. A. (1999) · Immunity · doi:10.1016/s1074-7613(00)80149-1 · Cited by 900
A STING-activating nanovaccine for cancer immunotherapy
Luo, M., Wang, H., Wang, Z., Cai, H., Lu, Z., Li, Y., Du, M., Huang, G., Wang, C., Chen, X., et al. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.52 · Cited by 900
Karikó, K., Muramatsu, H., Ludwig, J., & Weissman, D. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr695 · Cited by 898
Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies
Kanekiyo, M., Wei, C.-J., Yassine, H. M., McTamney, P. M., Boyington, J. C., Whittle, J. R. R., Rao, S. S., Kong, W.-P., Wang, L., & Nabel, G. J. (2013) · Nature · doi:10.1038/nature12202 · Cited by 885
Junt, T., Moseman, E. A., Iannacone, M., Massberg, S., Lang, P. A., Boes, M., Fink, K., Henrickson, S. E., Shayakhmetov, D. M., Di Paolo, N. C., et al. (2007) · Nature · doi:10.1038/nature06287 · Cited by 846
Henao-Restrepo, A. M., Longini, I. M., Egger, M., Dean, N. E., Edmunds, W. J., Camacho, A., Carroll, M. W., Doumbia, M., Draguez, B., Duraffour, S., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)61117-5 · Cited by 793
Rational HIV Immunogen Design to Target Specific Germline B Cell Receptors
Jardine, J., Julien, J.-P., Menis, S., Ota, T., Kalyuzhniy, O., McGuire, A., Sok, D., Huang, P.-S., MacPherson, S., Jones, M., et al. (2013) · Science · doi:10.1126/science.1234150 · Cited by 770
Synthetic Nanoparticles for Vaccines and Immunotherapy
Irvine, D. J., Hanson, M. C., Rakhra, K., & Tokatlian, T. (2015) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00109 · Cited by 763
Self-citationAllan, R. S., Waithman, J., Bedoui, S., Jones, C. M., Villadangos, J. A., Zhan, Y., Lew, A. M., Shortman, K., Heath, W. R., & Carbone, F. R. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.017 · Cited by 757
Sixt, M., Kanazawa, N., Selg, M., Samson, T., Roos, G., Reinhardt, D. P., Pabst, R., Lutz, M. B., & Sorokin, L. (2005) · Immunity · doi:10.1016/j.immuni.2004.11.013 · Cited by 747
Trimble, C. L., Morrow, M. P., Kraynyak, K. A., Shen, X., Dallas, M., Yan, J., Edwards, L., Parker, R. L., Denny, L., Giffear, M., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00239-1 · Cited by 727
Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy
Oberli, M. A., Reichmuth, A. M., Dorkin, J. R., Mitchell, M. J., Fenton, O. S., Jaklenec, A., Anderson, D. G., Langer, R., & Blankschtein, D. (2017) · Nano Letters · doi:10.1021/acs.nanolett.6b03329 · Cited by 719
Itano, A. A., McSorley, S. J., Reinhardt, R. L., Ehst, B. D., Ingulli, E., Rudensky, A. Y., & Jenkins, M. K. (2003) · Immunity · doi:10.1016/s1074-7613(03)00175-4 · Cited by 718
Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses
Morein, B., Sundquist, B., Höglund, S., Dalsgaard, K., & Osterhaus, A. (1984) · Nature · doi:10.1038/308457a0 · Cited by 708
Andries, O., Mc Cafferty, S., De Smedt, S. C., Weiss, R., Sanders, N. N., & Kitada, T. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.051 · Cited by 701
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
Reddy, S. T., Rehor, A., Schmoekel, H. G., Hubbell, J. A., & Swartz, M. A. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.006 · Cited by 679
Nonviral delivery of self-amplifying RNA vaccines
Geall, A. J., Verma, A., Otten, G. R., Shaw, C. A., Hekele, A., Banerjee, K., Cu, Y., Beard, C. W., Brito, L. A., Krucker, T., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209367109 · Cited by 675 · cited 3×
“mRNA is inherently unstable in vivo and antigen expression levels are significantly more transient than observed with DNA vaccination, typically only persisting for several days [183,275].”
Shae, D., Becker, K. W., Christov, P., Yun, D. S., Lytton-Jean, A. K. R., Sevimli, S., Ascano, M., Kelley, M., Johnson, D. B., Balko, J. M., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-018-0342-5 · Cited by 668
Subcapsular encounter and complement-dependent transport of immune complexes by lymph node B cells
Phan, T. G., Grigorova, I., Okada, T., & Cyster, J. G. (2007) · Nature Immunology · doi:10.1038/ni1494 · Cited by 656
From Sewer to Saviour—Targeting the Lymphatic System to Promote Drug Exposure and Activity
Trevaskis, N. L., Kaminskas, L. M., & Porter, C. J. H. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4608 · Cited by 654
Vaccine Adjuvants: from 1920 to 2015 and Beyond
Pasquale, A., Preiss, S., Silva, F., & Garçon, N. (2015) · Vaccines · doi:10.3390/vaccines3020320 · Cited by 648
Carrasco, Y. R., & Batista, F. D. (2007) · Immunity · doi:10.1016/j.immuni.2007.06.007 · Cited by 617
Kool, M., Pétrilli, V., De Smedt, T., Rolaz, A., Hammad, H., van Nimwegen, M., Bergen, I. M., Castillo, R., Lambrecht, B. N., & Tschopp, J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.6.3755 · Cited by 611
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Del Giudice, G., Rappuoli, R., & Didierlaurent, A. M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.001 · Cited by 610
Stabilization of proteins encapsulated in injectable poly (lactide- co-glycolide)
Zhu, G., Mallery, S. R., & Schwendeman, S. P. (2000) · Nature Biotechnology · doi:10.1038/71916 · Cited by 609
Clonal selection in the germinal centre by regulated proliferation and hypermutation
Gitlin, A. D., Shulman, Z., & Nussenzweig, M. C. (2014) · Nature · doi:10.1038/nature13300 · Cited by 591
Gretz, J. E., Norbury, C. C., Anderson, A. O., Proudfoot, A. E. I., & Shaw, S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.10.1425 · Cited by 583
Programmed contraction of CD8+ T cells after infection
Badovinac, V. P., Porter, B. B., & Harty, J. T. (2002) · Nature Immunology · doi:10.1038/ni804 · Cited by 578
Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
Pape, K. A., Taylor, J. J., Maul, R. W., Gearhart, P. J., & Jenkins, M. K. (2011) · Science · doi:10.1126/science.1201730 · Cited by 572
Epidermal Viral Immunity Induced by CD8α + Dendritic Cells But Not by Langerhans Cells
Allan, R. S., Smith, C. M., Belz, G. T., van Lint, A. L., Wakim, L. M., Heath, W. R., & Carbone, F. R. (2003) · Science · doi:10.1126/science.1087576 · Cited by 567
Moon, J. J., Suh, H., Bershteyn, A., Stephan, M. T., Liu, H., Huang, B., Sohail, M., Luo, S., Ho Um, S., Khant, H., et al. (2011) · Nature Materials · doi:10.1038/nmat2960 · Cited by 564
Self-citationPorgador, A., Irvine, K. R., Iwasaki, A., Barber, B. H., Restifo, N. P., & Germain, R. N. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.6.1075 · Cited by 560
Kim, J., Li, W. A., Choi, Y., Lewin, S. A., Verbeke, C. S., Dranoff, G., & Mooney, D. J. (2015) · Nature Biotechnology · doi:10.1038/nbt.3071 · Cited by 541
Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome
Sharp, F. A., Ruane, D., Claass, B., Creagh, E., Harris, J., Malyala, P., Singh, M., O'Hagan, D. T., Pétrilli, V., Tschopp, J., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804897106 · Cited by 540
A self-assembling peptide acting as an immune adjuvant
Rudra, J. S., Tian, Y. F., Jung, J. P., & Collier, J. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912124107 · Cited by 523
Extrafollicular Activation of Lymph Node B Cells by Antigen-Bearing Dendritic Cells
Qi, H., Egen, J. G., Huang, A. Y. C., & Germain, R. N. (2006) · Science · doi:10.1126/science.1125703 · Cited by 520
Modulating Antibacterial Immunity via Bacterial Membrane-Coated Nanoparticles
Gao, W., Fang, R. H., Thamphiwatana, S., Luk, B. T., Li, J., Angsantikul, P., Zhang, Q., Hu, C.-M. J., & Zhang, L. (2015) · Nano Letters · doi:10.1021/nl504798g · Cited by 509
Vogel, A. B., Lambert, L., Kinnear, E., Busse, D., Erbar, S., Reuter, K. C., Wicke, L., Perkovic, M., Beissert, T., Haas, H., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2017.11.017 · Cited by 501
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Baumjohann, D., Preite, S., Reboldi, A., Ronchi, F., Ansel, K. M., Lanzavecchia, A., & Sallusto, F. (2013) · Immunity · doi:10.1016/j.immuni.2012.11.020 · Cited by 484
JIANG, W., GUPTA, R., DESHPANDE, M., & SCHWENDEMAN, S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.003 · Cited by 478
Early Programming of T Cell Populations Responding to Bacterial Infection
Mercado, R., Vijh, S., Allen, S. E., Kerksiek, K., Pilip, I. M., & Pamer, E. G. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.6833 · Cited by 477
Biomaterial-assisted targeted modulation of immune cells in cancer treatment
Wang, H., & Mooney, D. J. (2018) · Nature Materials · doi:10.1038/s41563-018-0147-9 · Cited by 467
Surface Functionalization of Gold Nanoparticles with Red Blood Cell Membranes
Gao, W., Hu, C. J., Fang, R. H., Luk, B. T., Su, J., & Zhang, L. (2013) · Advanced Materials · doi:10.1002/adma.201300638 · Cited by 465
McKay, P. F., Hu, K., Blakney, A. K., Samnuan, K., Brown, J. C., Penn, R., Zhou, J., Bouton, C. R., Rogers, P., Polra, K., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17409-9 · Cited by 462
Material design for lymph node drug delivery
Schudel, A., Francis, D. M., & Thomas, S. N. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0110-7 · Cited by 460
Hailemichael, Y., Dai, Z., Jaffarzad, N., Ye, Y., Medina, M. A., Huang, X.-F., Dorta-Estremera, S. M., Greeley, N. R., Nitti, G., Peng, W., et al. (2013) · Nature Medicine · doi:10.1038/nm.3105 · Cited by 457
Feldman, R. A., Fuhr, R., Smolenov, I., (Mick) Ribeiro, A., Panther, L., Watson, M., Senn, J. J., Smith, M., Almarsson, Ӧ., Pujar, H. S., et al. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.074 · Cited by 454 · cited 1×
“Recent clinical trials from Moderna using intramuscular delivery of nucleosidemodified RNA show thatmRNA vaccines are safe and capable of inducing effective humoral responses against H10N8 and H7N9 influenza strains in humans [294].”
HIV-1 broadly neutralizing antibody precursor B cells revealed by germline-targeting immunogen
Jardine, J. G., Kulp, D. W., Havenar-Daughton, C., Sarkar, A., Briney, B., Sok, D., Sesterhenn, F., Ereño-Orbea, J., Kalyuzhniy, O., Deresa, I., et al. (2016) · Science · doi:10.1126/science.aad9195 · Cited by 450
Marcandalli, J., Fiala, B., Ols, S., Perotti, M., de van der Schueren, W., Snijder, J., Hodge, E., Benhaim, M., Ravichandran, R., Carter, L., et al. (2019) · Cell · doi:10.1016/j.cell.2019.01.046 · Cited by 448
Conduits Mediate Transport of Low-Molecular-Weight Antigen to Lymph Node Follicles
Roozendaal, R., Mempel, T. R., Pitcher, L. A., Gonzalez, S. F., Verschoor, A., Mebius, R. E., von Andrian, U. H., & Carroll, M. C. (2009) · Immunity · doi:10.1016/j.immuni.2008.12.014 · Cited by 444
Lynn, G. M., Laga, R., Darrah, P. A., Ishizuka, A. S., Balaci, A. J., Dulcey, A. E., Pechar, M., Pola, R., Gerner, M. Y., Yamamoto, A., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3371 · Cited by 440
Enhanced CAR–T cell activity against solid tumors by vaccine boosting through the chimeric receptor
Ma, L., Dichwalkar, T., Chang, J. Y. H., Cossette, B., Garafola, D., Zhang, A. Q., Fichter, M., Wang, C., Liang, S., Silva, M., et al. (2019) · Science · doi:10.1126/science.aav8692 · Cited by 439
Self-citationDevelopments in Viral Vector-Based Vaccines
Ura, T., Okuda, K., & Shimada, M. (2014) · Vaccines · doi:10.3390/vaccines2030624 · Cited by 436
Reverse vaccinology 2.0: Human immunology instructs vaccine antigen design
Rappuoli, R., Bottomley, M. J., D’Oro, U., Finco, O., & De Gregorio, E. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151960 · Cited by 435
Besch, R., Poeck, H., Hohenauer, T., Senft, D., Häcker, G., Berking, C., Hornung, V., Endres, S., Ruzicka, T., Rothenfusser, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37155 · Cited by 433
Calabro, S., Tortoli, M., Baudner, B. C., Pacitto, A., Cortese, M., O’Hagan, D. T., De Gregorio, E., Seubert, A., & Wack, A. (2011) · Vaccine · doi:10.1016/j.vaccine.2010.12.090 · Cited by 433
Cirelli, K. M., Carnathan, D. G., Nogal, B., Martin, J. T., Rodriguez, O. L., Upadhyay, A. A., Enemuo, C. A., Gebru, E. H., Choe, Y., Viviano, F., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.012 · Cited by 433
Self-citationTam, H. H., Melo, M. B., Kang, M., Pelet, J. M., Ruda, V. M., Foley, M. H., Hu, J. K., Kumari, S., Crampton, J., Baldeon, A. D., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606050113 · Cited by 425
Self-citationPhan, T. G., Green, J. A., Gray, E. E., Xu, Y., & Cyster, J. G. (2009) · Nature Immunology · doi:10.1038/ni.1745 · Cited by 425
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen
Jardine, J. G., Ota, T., Sok, D., Pauthner, M., Kulp, D. W., Kalyuzhniy, O., Skog, P. D., Thinnes, T. C., Bhullar, D., Briney, B., et al. (2015) · Science · doi:10.1126/science.aac5894 · Cited by 420
Injectable cryogel-based whole-cell cancer vaccines
Bencherif, S. A., Warren Sands, R., Ali, O. A., Li, W. A., Lewin, S. A., Braschler, T. M., Shih, T.-Y., Verbeke, C. S., Bhatta, D., Dranoff, G., et al. (2015) · Nature Communications · doi:10.1038/ncomms8556 · Cited by 416
Electroporation delivery of DNA vaccines: prospects for success
Sardesai, N. Y., & Weiner, D. B. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.03.008 · Cited by 416
Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414
Alum interaction with dendritic cell membrane lipids is essential for its adjuvanticity
Flach, T. L., Ng, G., Hari, A., Desrosiers, M. D., Zhang, P., Ward, S. M., Seamone, M. E., Vilaysane, A., Mucsi, A. D., Fong, Y., et al. (2011) · Nature Medicine · doi:10.1038/nm.2306 · Cited by 405
Cell Surface Recycling of Internalized Antigen Permits Dendritic Cell Priming of B Cells
Bergtold, A., Desai, D. D., Gavhane, A., & Clynes, R. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.013 · Cited by 401
Dynamic signaling by T follicular helper cells during germinal center B cell selection
Shulman, Z., Gitlin, A. D., Weinstein, J. S., Lainez, B., Esplugues, E., Flavell, R. A., Craft, J. E., & Nussenzweig, M. C. (2014) · Science · doi:10.1126/science.1257861 · Cited by 391
Optimizing the utilization of aluminum adjuvants in vaccines: you might just get what you want
HogenEsch, H., O’Hagan, D. T., & Fox, C. B. (2018) · npj Vaccines · doi:10.1038/s41541-018-0089-x · Cited by 391
Supersaxo, A., Hein, W. R., & Steffen, H. (1990) · Pharmaceutical Research · doi:10.1023/a:1015880819328 · Cited by 386
Nanoparticulate STING agonists are potent lymph node–targeted vaccine adjuvants
Hanson, M. C., Crespo, M. P., Abraham, W., Moynihan, K. D., Szeto, G. L., Chen, S. H., Melo, M. B., Mueller, S., & Irvine, D. J. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79915 · Cited by 381
Self-citationBeyond antigens and adjuvants: formulating future vaccines
Moyer, T. J., Zmolek, A. C., & Irvine, D. J. (2016) · Journal of Clinical Investigation · doi:10.1172/jci81083 · Cited by 374
Self-citationDhodapkar, M. V., Sznol, M., Zhao, B., Wang, D., Carvajal, R. D., Keohan, M. L., Chuang, E., Sanborn, R. E., Lutzky, J., Powderly, J., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008068 · Cited by 365
Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356
Lynn, G. M., Sedlik, C., Baharom, F., Zhu, Y., Ramirez-Valdez, R. A., Coble, V. L., Tobin, K., Nichols, S. R., Itzkowitz, Y., Zaidi, N., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-019-0390-x · Cited by 349
Virus‐like particles: Next‐generation nanoparticles for targeted therapeutic delivery
Rohovie, M. J., Nagasawa, M., & Swartz, J. R. (2017) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10049 · Cited by 340
B cell follicles and antigen encounters of the third kind
Cyster, J. G. (2010) · Nature Immunology · doi:10.1038/ni.1946 · Cited by 339
Molecular mechanisms for enhanced DNA vaccine immunogenicity
Li, L., & Petrovsky, N. (2016) · Expert Review of Vaccines · doi:10.1586/14760584.2016.1124762 · Cited by 335
Next-generation influenza vaccines: opportunities and challenges
Wei, C.-J., Crank, M. C., Shiver, J., Graham, B. S., Mascola, J. R., & Nabel, G. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0056-x · Cited by 332
Malaria Vaccines: Recent Advances and New Horizons
Draper, S. J., Sack, B. K., King, C. R., Nielsen, C. M., Rayner, J. C., Higgins, M. K., Long, C. A., & Seder, R. A. (2018) · Cell Host & Microbe · doi:10.1016/j.chom.2018.06.008 · Cited by 331
Distribution of DNA Vaccines Determines Their Immunogenicity After Intramuscular Injection in Mice
Dupuis, M., Denis-Mize, K., Woo, C., Goldbeck, C., Selby, M. J., Chen, M., Otten, G. R., Ulmer, J. B., Donnelly, J. J., Ott, G., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.5.2850 · Cited by 327
Maciag, P. C., Radulovic, S., & Rothman, J. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.04.041 · Cited by 324
Alum adjuvant: some of the tricks of the oldest adjuvant
Kool, M., Fierens, K., & Lambrecht, B. N. (2012) · Journal of Medical Microbiology · doi:10.1099/jmm.0.038943-0 · Cited by 318
Stimulation History Dictates Memory CD8 T Cell Phenotype: Implications for Prime-Boost Vaccination
Masopust, D., Ha, S.-J., Vezys, V., & Ahmed, R. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.2.831 · Cited by 315
Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy
Zhu, G., Lynn, G. M., Jacobson, O., Chen, K., Liu, Y., Zhang, H., Ma, Y., Zhang, F., Tian, R., Ni, Q., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-02191-y · Cited by 315
Complex Antigens Drive Permissive Clonal Selection in Germinal Centers
Kuraoka, M., Schmidt, A. G., Nojima, T., Feng, F., Watanabe, A., Kitamura, D., Harrison, S. C., Kepler, T. B., & Kelsoe, G. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.010 · Cited by 313
Moon, J. J., Suh, H., Li, A. V., Ockenhouse, C. F., Yadava, A., & Irvine, D. J. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112648109 · Cited by 312
Self-citationPauthner, M., Havenar-Daughton, C., Sok, D., Nkolola, J. P., Bastidas, R., Boopathy, A. V., Carnathan, D. G., Chandrashekar, A., Cirelli, K. M., Cottrell, C. A., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.05.007 · Cited by 305
Self-citationInnate immune recognition of glycans targets HIV nanoparticle immunogens to germinal centers
Tokatlian, T., Read, B. J., Jones, C. A., Kulp, D. W., Menis, S., Chang, J. Y. H., Steichen, J. M., Kumari, S., Allen, J. D., Dane, E. L., et al. (2019) · Science · doi:10.1126/science.aat9120 · Cited by 305
Self-citationRole of sustained antigen release from nanoparticle vaccines in shaping the T cell memory phenotype
Demento, S. L., Cui, W., Criscione, J. M., Stern, E., Tulipan, J., Kaech, S. M., & Fahmy, T. M. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.03.041 · Cited by 304
Heesters, B. A., Chatterjee, P., Kim, Y.-A., Gonzalez, S. F., Kuligowski, M. P., Kirchhausen, T., & Carroll, M. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.023 · Cited by 300
Listeria-based cancer vaccines that segregate immunogenicity from toxicity
Brockstedt, D. G., Giedlin, M. A., Leong, M. L., Bahjat, K. S., Gao, Y., Luckett, W., Liu, W., Cook, D. N., Portnoy, D. A., & Dubensky, T. W. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406035101 · Cited by 299
Gerner, M. Y., Torabi-Parizi, P., & Germain, R. N. (2015) · Immunity · doi:10.1016/j.immuni.2014.12.024 · Cited by 299
Lymph node targeting strategies to improve vaccination efficacy
Jiang, H., Wang, Q., & Sun, X. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.08.009 · Cited by 297
PRINT: A Novel Platform Toward Shape and Size Specific Nanoparticle Theranostics
Perry, J. L., Herlihy, K. P., Napier, M. E., & DeSimone, J. M. (2011) · Accounts of Chemical Research · doi:10.1021/ar2000315 · Cited by 290
Germinal center B cells govern their own fate via antibody feedback
Zhang, Y., Meyer-Hermann, M., George, L. A., Figge, M. T., Khan, M., Goodall, M., Young, S. P., Reynolds, A., Falciani, F., Waisman, A., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20120150 · Cited by 288
Ben Mkaddem, S., Benhamou, M., & Monteiro, R. C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00811 · Cited by 283
Immunotherapy Against HPV16/18 Generates Potent T H 1 and Cytotoxic Cellular Immune Responses
Bagarazzi, M. L., Yan, J., Morrow, M. P., Shen, X., Parker, R. L., Lee, J. C., Giffear, M., Pankhong, P., Khan, A. S., Broderick, K. E., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004414 · Cited by 282
Huttner, A., Dayer, J.-A., Yerly, S., Combescure, C., Auderset, F., Desmeules, J., Eickmann, M., Finckh, A., Goncalves, A. R., Hooper, J. W., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00154-1 · Cited by 272
Nabel, G. J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1204186 · Cited by 271
The microanatomic segregation of selection by apoptosis in the germinal center
Mayer, C. T., Gazumyan, A., Kara, E. E., Gitlin, A. D., Golijanin, J., Viant, C., Pai, J., Oliveira, T. Y., Wang, Q., Escolano, A., et al. (2017) · Science · doi:10.1126/science.aao2602 · Cited by 270
Gradated assembly of multiple proteins into supramolecular nanomaterials
Hudalla, G. A., Sun, T., Gasiorowski, J. Z., Han, H., Tian, Y. F., Chong, A. S., & Collier, J. H. (2014) · Nature Materials · doi:10.1038/nmat3998 · Cited by 269
Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses
Boscardin, S. B., Hafalla, J. C. R., Masilamani, R. F., Kamphorst, A. O., Zebroski, H. A., Rai, U., Morrot, A., Zavala, F., Steinman, R. M., Nussenzweig, R. S., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051639 · Cited by 269
Antigen persistence is required throughout the expansion phase of a CD4+ T cell response
Obst, R., van Santen, H.-M., Mathis, D., & Benoist, C. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20042521 · Cited by 269
Didierlaurent, A. M., Collignon, C., Bourguignon, P., Wouters, S., Fierens, K., Fochesato, M., Dendouga, N., Langlet, C., Malissen, B., Lambrecht, B. N., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400948 · Cited by 266
Subcutaneous drug delivery and the role of the lymphatics
McLennan, D. N., Porter, C. J. H., & Charman, S. A. (2005) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2005.05.006 · Cited by 259
Immunomodulatory spherical nucleic acids
Radovic-Moreno, A. F., Chernyak, N., Mader, C. C., Nallagatla, S., Kang, R. S., Hao, L., Walker, D. A., Halo, T. L., Merkel, T. J., Rische, C. H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1502850112 · Cited by 259
Inducing Mucosal IgA: A Challenge for Vaccine Adjuvants and Delivery Systems
Boyaka, P. N. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601775 · Cited by 257
Prime-boost vaccine strategy against viral infections: Mechanisms and benefits
Kardani, K., Bolhassani, A., & Shahbazi, S. (2016) · Vaccine · doi:10.1016/j.vaccine.2015.11.062 · Cited by 255
Engineered immunogen binding to alum adjuvant enhances humoral immunity
Moyer, T. J., Kato, Y., Abraham, W., Chang, J. Y. H., Kulp, D. W., Watson, N., Turner, H. L., Menis, S., Abbott, R. K., Bhiman, J. N., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0753-3 · Cited by 252
Self-citationIn Situ Regulation of DC Subsets and T Cells Mediates Tumor Regression in Mice
Ali, O. A., Emerich, D., Dranoff, G., & Mooney, D. J. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000359 · Cited by 246
T-Cell-Receptor-Dependent Signal Intensity Dominantly Controls CD4+ T Cell Polarization In Vivo
van Panhuys, N., Klauschen, F., & Germain, R. N. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.003 · Cited by 246
Jewell, C. M., Bustamante López, S. C., & Irvine, D. J. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105200108 · Cited by 245
Self-citationAntigen depot is not required for alum adjuvanticity
Hutchison, S., Benson, R. A., Gibson, V. B., Pollock, A. H., Garside, P., & Brewer, J. M. (2012) · The FASEB Journal · doi:10.1096/fj.11-184556 · Cited by 244
van Dissel, J. T., Joosten, S. A., Hoff, S. T., Soonawala, D., Prins, C., Hokey, D. A., O’Dee, D. M., Graves, A., Thierry-Carstensen, B., Andreasen, L. V., et al. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.10.036 · Cited by 243
Gonzalez, S. F., Lukacs-Kornek, V., Kuligowski, M. P., Pitcher, L. A., Degn, S. E., Kim, Y.-A., Cloninger, M. J., Martinez-Pomares, L., Gordon, S., Turley, S. J., et al. (2010) · Nature Immunology · doi:10.1038/ni.1856 · Cited by 243
O'Hagan, D. (1998) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(98)00012-x · Cited by 243
Immunologic Basis of Vaccine Vectors
Liu, M. A. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.004 · Cited by 237
Cruz, L. J., Rosalia, R. A., Kleinovink, J. W., Rueda, F., Löwik, C. W. G. M., & Ossendorp, F. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.07.040 · Cited by 235
Structure-Based Vaccine Antigen Design
Graham, B. S., Gilman, M. S. A., & McLellan, J. S. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-121217-094234 · Cited by 234
Antigen-specific therapeutic approaches for autoimmunity
Serra, P., & Santamaria, P. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0015-4 · Cited by 228
Kuhn, A. N., Diken, M., Kreiter, S., Selmi, A., Kowalska, J., Jemielity, J., Darzynkiewicz, E., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Gene Therapy · doi:10.1038/gt.2010.52 · Cited by 226
T cell help controls the speed of the cell cycle in germinal center B cells
Gitlin, A. D., Mayer, C. T., Oliveira, T. Y., Shulman, Z., Jones, M. J. K., Koren, A., & Nussenzweig, M. C. (2015) · Science · doi:10.1126/science.aac4919 · Cited by 223
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activation
Nuhn, L., Vanparijs, N., De Beuckelaer, A., Lybaert, L., Verstraete, G., Deswarte, K., Lienenklaus, S., Shukla, N. M., Salyer, A. C. D., Lambrecht, B. N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600816113 · Cited by 213
Fabrication of fillable microparticles and other complex 3D microstructures
McHugh, K. J., Nguyen, T. D., Linehan, A. R., Yang, D., Behrens, A. M., Rose, S., Tochka, Z. L., Tzeng, S. Y., Norman, J. J., Anselmo, A. C., et al. (2017) · Science · doi:10.1126/science.aaf7447 · Cited by 211
Rational antibody-based HIV-1 vaccine design: current approaches and future directions
Walker, L. M., & Burton, D. R. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.02.012 · Cited by 210
Liang, F., Lindgren, G., Sandgren, K. J., Thompson, E. A., Francica, J. R., Seubert, A., De Gregorio, E., Barnett, S., O’Hagan, D. T., Sullivan, N. J., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2094 · Cited by 209
The development of polyanhydrides for drug delivery applications
Tamada, J., & Langer, R. (1992) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856292x00402 · Cited by 207
Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
Marty-Roix, R., Vladimer, G. I., Pouliot, K., Weng, D., Buglione-Corbett, R., West, K., MacMicking, J. D., Chee, J. D., Wang, S., Lu, S., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.683011 · Cited by 204
Rantakari, P., Auvinen, K., Jäppinen, N., Kapraali, M., Valtonen, J., Karikoski, M., Gerke, H., Iftakhar-E-Khuda, I., Keuschnigg, J., Umemoto, E., et al. (2015) · Nature Immunology · doi:10.1038/ni.3101 · Cited by 203
Kuek, V., Yang, Z., Chim, S. M., Zhu, S., Xu, H., Chow, S. T., Tickner, J., Rosen, V., Erber, W., Li, X., et al. (2016) · Scientific Reports · doi:10.1038/srep37482 · Cited by 202
Barouch, D. H., Craiu, A., Kuroda, M. J., Schmitz, J. E., Zheng, X. X., Santra, S., Frost, J. D., Krivulka, G. R., Lifton, M. A., Crabbs, C. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050417697 · Cited by 200
Enhancing humoral immunity via sustained-release implantable microneedle patch vaccination
Boopathy, A. V., Mandal, A., Kulp, D. W., Menis, S., Bennett, N. R., Watkins, H. C., Wang, W., Martin, J. T., Thai, N. T., He, Y., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1902179116 · Cited by 198
Self-citationZhang, Y.-N., Lazarovits, J., Poon, W., Ouyang, B., Nguyen, L. N. M., Kingston, B. R., & Chan, W. C. W. (2019) · Nano Letters · doi:10.1021/acs.nanolett.9b02834 · Cited by 198
McKee, A. S., & Marrack, P. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.06.005 · Cited by 197
The status of tuberculosis vaccine development
Schrager, L. K., Vekemens, J., Drager, N., Lewinsohn, D. M., & Olesen, O. F. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(19)30625-5 · Cited by 196
A single-step immunization by sustained antigen release
Preis, I., & Langer, R. S. (1979) · Journal of Immunological Methods · doi:10.1016/0022-1759(79)90341-7 · Cited by 193
Glenny, A. T., Buttle, G. A. H., & Stevens, M. F. (1931) · The Journal of Pathology and Bacteriology · doi:10.1002/path.1700340214 · Cited by 192
Sliepen, K., Ozorowski, G., Burger, J. A., van Montfort, T., Stunnenberg, M., LaBranche, C., Montefiori, D. C., Moore, J. P., Ward, A. B., & Sanders, R. W. (2015) · Retrovirology · doi:10.1186/s12977-015-0210-4 · Cited by 184
Antigen kinetics determines immune reactivity
Johansen, P., Storni, T., Rettig, L., Qiu, Z., Der-Sarkissian, A., Smith, K. A., Manolova, V., Lang, K. S., Senti, G., Müllhaupt, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706296105 · Cited by 184
Brouwer, P. J. M., Antanasijevic, A., Berndsen, Z., Yasmeen, A., Fiala, B., Bijl, T. P. L., Bontjer, I., Bale, J. B., Sheffler, W., Allen, J. D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12080-1 · Cited by 184
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticles
He, L., de Val, N., Morris, C. D., Vora, N., Thinnes, T. C., Kong, L., Azadnia, P., Sok, D., Zhou, B., Burton, D. R., et al. (2016) · Nature Communications · doi:10.1038/ncomms12041 · Cited by 182
Almeida, J. P. M., Lin, A. Y., Figueroa, E. R., Foster, A. E., & Drezek, R. A. (2015) · Small · doi:10.1002/smll.201402179 · Cited by 181
The future of human DNA vaccines
Li, L., Saade, F., & Petrovsky, N. (2012) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2012.08.012 · Cited by 181
HPLC purification of in vitro transcribed long RNA
Weissman, D., Pardi, N., Muramatsu, H., & Karikó, K. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-260-5_3 · Cited by 180
Dendritic cell and antigen dispersal landscapes regulate T cell immunity
Gerner, M. Y., Casey, K. A., Kastenmuller, W., & Germain, R. N. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20170335 · Cited by 180
Havenar‐Daughton, C., Lee, J. H., & Crotty, S. (2017) · Immunological Reviews · doi:10.1111/imr.12512 · Cited by 179
Virus-like particle vaccines: immunology and formulation for clinical translation
Donaldson, B., Lateef, Z., Walker, G. F., Young, S. L., & Ward, V. K. (2018) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1516552 · Cited by 179
Self-assembled peptide nanofibers raising durable antibody responses against a malaria epitope
Rudra, J. S., Mishra, S., Chong, A. S., Mitchell, R. A., Nardin, E. H., Nussenzweig, V., & Collier, J. H. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.05.041 · Cited by 176
Rational design of small molecules as vaccine adjuvants
Wu, T. Y.-H., Singh, M., Miller, A. T., De Gregorio, E., Doro, F., D’Oro, U., Skibinski, D. A. G., Mbow, M. L., Bufali, S., Herman, A. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009980 · Cited by 176
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice
Sok, D., Briney, B., Jardine, J. G., Kulp, D. W., Menis, S., Pauthner, M., Wood, A., Lee, E.-C., Le, K. M., Jones, M., et al. (2016) · Science · doi:10.1126/science.aah3945 · Cited by 176
Henriksen‐Lacey, M., Christensen, D., Bramwell, V. W., Lindenstrøm, T., Agger, E. M., Andersen, P. L., & Perrie, Y. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.03.027 · Cited by 175
Kipper, M. J., Shen, E., Determan, A. S., & Narasimhan, B. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00181-3 · Cited by 175
How Follicular Dendritic Cells Shape the B-Cell Antigenome
Kranich, J., & Kräutler, N. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00225 · Cited by 168
Pauthner, M. G., Nkolola, J. P., Havenar-Daughton, C., Murrell, B., Reiss, S. M., Bastidas, R., Prévost, J., Nedellec, R., von Bredow, B., Abbink, P., et al. (2019) · Immunity · doi:10.1016/j.immuni.2018.11.011 · Cited by 163
Self-citationInnate Immunity Mediates Follicular Transport of Particulate but Not Soluble Protein Antigen
Link, A., Zabel, F., Schnetzler, Y., Titz, A., Brombacher, F., & Bachmann, M. F. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103312 · Cited by 162
Erasmus, J. H., Khandhar, A. P., Guderian, J., Granger, B., Archer, J., Archer, M., Gage, E., Fuerte-Stone, J., Larson, E., Lin, S., et al. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.07.010 · Cited by 161
Lindenstrøm, T., Knudsen, N. P. H., Agger, E. M., & Andersen, P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300248 · Cited by 159
He, Y., Zhang, J., Mi, Z., Robbins, P. D., & Falo, L. D. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.6.3808 · Cited by 152
Immunogenic Display of Diverse Peptides on Virus-like Particles of RNA Phage MS2
Peabody, D. S., Manifold-Wheeler, B. C., Medford, A., Jordan, S. K., Caldeira, J. C., & Chackerian, B. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.04.049 · Cited by 152
Route of Vaccine Administration Alters Antigen Trafficking but Not Innate or Adaptive Immunity
Ols, S., Yang, L., Thompson, E. A., Pushparaj, P., Tran, K., Liang, F., Lin, A., Eriksson, B. M., Hedestam, G. B. K., Wyatt, R. T., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.111 · Cited by 151
Ghimire, T. R., Benson, R. A., Garside, P., & Brewer, J. M. (2012) · Immunology Letters · doi:10.1016/j.imlet.2012.06.002 · Cited by 149
Liposomal vaccine delivery systems
Henriksen‐Lacey, M., Korsholm, K. S., Andersen, P. L., Perrie, Y., & Christensen, D. (2011) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2011.558081 · Cited by 149
Kim, S., Noh, Y., Kang, T. H., Kim, J., Kim, S., Um, S. H., Oh, D., Park, Y., & Lim, Y. T. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2017.03.034 · Cited by 149
A malaria vaccine adjuvant based on recombinant antigen binding to liposomes
Huang, W.-C., Deng, B., Lin, C., Carter, K. A., Geng, J., Razi, A., He, X., Chitgupi, U., Federizon, J., Sun, B., et al. (2018) · Nature Nanotechnology · doi:10.1038/s41565-018-0271-3 · Cited by 148
Hu, J. K., Crampton, J. C., Cupo, A., Ketas, T. J., van Gils, M. J., Sliepen, K., de Taeye, S. W., Sok, D., Ozorowski, G., Deresa, I., et al. (2015) · Journal of Virology · doi:10.1128/jvi.01653-15 · Cited by 147
Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8+ T Cell Responses
Jiang, H., Wang, Q., Li, L., Zeng, Q., Li, H., Gong, T., Zhang, Z., & Sun, X. (2017) · Advanced Science · doi:10.1002/advs.201700426 · Cited by 142
Kusakabe, K., Xin, K.-Q., Katoh, H., Sumino, K., Hagiwara, E., Kawamoto, S., Okuda, K., Miyagi, Y., Aoki, I., Nishioka, K., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.6.3102 · Cited by 139
Sliepen, K., Han, B. W., Bontjer, I., Mooij, P., Garcés, F., Behrens, A., Rantalainen, K. I., Kumar, S., Sarkar, A., Brouwer, P. J. M., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10262-5 · Cited by 138
Ulery, B. D., Kumar, D., Ramer‐Tait, A. E., Metzger, D. W., Wannemuehler, M. J., & Narasimhan, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0017642 · Cited by 137
Ingale, J., Stano, A., Guenaga, J., Sharma, S. K., Nemazee, D. A., Zwick, M. B., & Wyatt, R. T. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.078 · Cited by 137
Bloom, B. R. (1989) · Nature · doi:10.1038/342115a0 · Cited by 136
Potentiation of the immune response to non-adsorbed antigens by aluminum-containing adjuvants
Méndez, I. Z. R., Shi, Y., HogenEsch, H., & Hem, S. L. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.039 · Cited by 136
Pompano, R. R., Chen, J., Verbus, E. A., Han, H., Fridman, A., McNeely, T. B., Collier, J. H., & Chong, A. S. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201400137 · Cited by 132
Cited by
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Translational Applications of Hydrogels
Correa, S., Grosskopf, A. K., Lopez Hernandez, H., Chan, D., Yu, A. C., Stapleton, L. M., & Appel, E. A. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01177 · Cited by 1,143
Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514
A Comprehensive Review of mRNA Vaccines
Gote, V., Bolla, P. K., Kommineni, N., Butreddy, A., Nukala, P. K., Palakurthi, S. S., & Khan, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032700 · Cited by 457
Metadata
- Authors
- Irvine, D. J., Aung, A., & Silva, M.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2020
- Volume
- 158
- Pages
- 91-115
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3038037714
- Cited by
- 254
- References
- 314
- FWCI
- 2.60
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.